Promoting immune health by intermittent fasting: a pilot study
- Conditions
- metabolic syndrome10018424
- Registration Number
- NL-OMON51683
- Lead Sponsor
- Amsterdam UMC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 24
the at-risk group:
• Body mass index (BMI) 30 to 43 kg/m2)
• HOMA-IR index of >= 2.5 (measured as fasting insulin (pmol/L) x fasting
glucose (mmol/L)) / 135)
• At least 3 out of 5 NCEP metabolic syndrome criteria
Healthy group
• Body mass index (BMI) 18 to 25 kg/m2,
• Waist circumference between 79 cm and 94 cm,
• HOMA-IR index <= 2.0
- Excessive weight loss of >10% in the last months;
- Use of any medication
- Pregnant, trying to get pregnant or breast feeding at inclusion;
- Irregular menstrual cycle;
- Hormonal replacement therapy.
- Cholecystectomy;
- Untreated GI disease/abnormal bowel habits;
- A history of cardiovascular event (MI or pacemaker implantation)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary objective is to determine the direct effects of long-term<br /><br>intermittent fasting on immune cell populations in the blood, combined with<br /><br>analyses of systemic metabolic fitness and inflammatory activation of<br /><br>leukocytes.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary objectives are to determine:<br /><br>- Shifts in immune cell populations and inflammatory activation of leukocytes.<br /><br>- The effect of IF on the transcriptional and epigenetic repertoire of<br /><br>monocytes.<br /><br>- The fitness of monocyte responses by analysing their response to an<br /><br>inflammatory metabolic challenge (i.e., mixed meal challenge).<br /><br>- The effect of IF on metabolic parameters such as body weight, resting energy<br /><br>expenditure, insulin sensitivity, glucose tolerance and postprandial bile acid<br /><br>and FGF-19 responses.<br /><br>- The effect of IF on gut microbiota.</p><br>